Commit To Purchase Akebia Therapeutics At $7.50, Earn 13.9% Annualized Using Options
August 14, 2018 at 11:59 AM EDT
Investors eyeing a purchase of Akebia Therapeutics Inc (AKBA) shares, but tentative about paying the going market price of $8.04/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $7.50 strike, which has a bid at the time of this writing of 45 cents..